Sophia Lu
Boston University(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Hepatitis C virus research, Hormonal and reproductive studies, Estrogen and related hormone effects, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis(2019)123 cited
- → Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial(2018)120 cited
- → Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial(2016)60 cited
- → Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial(2016)53 cited
- → Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt(2018)46 cited
- → Proteins as Mediators of the Association Between Diet Quality and Incident Cardiovascular Disease and All‐Cause Mortality: The Framingham Heart Study(2021)26 cited
- → Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes(2024)25 cited
- → Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India(2019)22 cited
- → Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study(2023)19 cited
- → Association Between Acoustic Features and Neuropsychological Test Performance in the Framingham Heart Study: Observational Study(2022)17 cited